Healthcare Industry News: HSMN NewsFeed
News Release - October 3, 2018
Tom Polen Promoted to Chief Operating Officer of BDFRANKLIN LAKES, N.J., Oct. 3, 2018 -- (Healthcare Sales & Marketing Network) -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Tom Polen will add the responsibility of chief operating officer of BD, in addition to his current role as president. Polen continues to report Vincent A. Forlenza, chairman and CEO.
As president and chief operating officer, Polen will have oversight of BD's three operating segments, its innovation and new product development pipeline, and global operations for the company, including all manufacturing facilities and supply chain operations.
"Tom's promotion reflects his leadership role developing and implementing BD's strategy and vision and aligning our businesses under three strong segment leaders," said Forlenza. "Tom's priority of driving innovation to create category leadership, as well as his focus on integrating Bard and enhancing the customer experience, will help guide our segments, R&D portfolio and global operations as we continue to shape BD into a partner of choice for the global health care industry."
Polen was appointed president of BD in April 2017. The company has not had a chief operating officer role since 2016.
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 65,000 employees have a passion and commitment to help improve patient outcomes, improve the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to better diagnose disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. In 2017, BD welcomed C. R. Bard and its products into the BD family. For more information on BD, please visit bd.com.
Source: Becton, Dickinson
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.
Related News ItemsBD Unveils Platelet Quality Control Media to Help Reduce the Incidence of Sepsis in Patients Requiring Platelet Transfusion
BD Receives U.S. FDA Approval for First Venous Stent to Treat Iliofemoral Venous Occlusive Disease
BD Launches Ergonomic Pen Needle Technology to Help Optimize Injection Technique